Telbivudine (LdT) vs. lamivudine for chronic hepatitis B: First-year results from the international phase III globe trial

被引：0

作者：

Lai, CL

Gane, E

Liaw, YF

Thongsawat, S

Wang, YM

Chen, YG

Heathcote, EJ

Rasenack, J

Bzowej, N

Naoumov, N

Chao, G

Constance, BF

Brown, NA

机构：

[1] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China

[2] Middlemore Hosp, Auckland 6, New Zealand

[3] Chang Gung Univ, Taipei, Taiwan

[4] Chang Gung Mem Hosp, Taipei 10591, Taiwan

[5] Chiang Mai Univ, Fac Med, Chiang Mai 50000, Thailand

[6] Third Mil Med Univ, Chongqing, Peoples R China

[7] Zhejiang Univ, Coll Med, Hangzhou 310027, Peoples R China

[8] Univ Toronto, Toronto, ON, Canada

[9] Univ Freiburg, Freiburg, Germany

[10] Sutter Hlth, San Francisco, CA USA

[11] UCL, London, England

[12] Idenix Pharmaceut Inc, Cambridge, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：748A / 748A

页数：1